These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Dold M; Aigner M; Lanzenberger R; Kasper S Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229 [TBL] [Abstract][Full Text] [Related]
37. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study. Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567 [TBL] [Abstract][Full Text] [Related]
38. Commonly asked questions in the treatment of obsessive-compulsive disorder. Arumugham SS; Reddy YC Expert Rev Neurother; 2014 Feb; 14(2):151-63. PubMed ID: 24372473 [TBL] [Abstract][Full Text] [Related]
39. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. Stewart SE; Jenike EA; Hezel DM; Stack DE; Dodman NH; Shuster L; Jenike MA J Clin Psychopharmacol; 2010 Feb; 30(1):34-9. PubMed ID: 20075645 [TBL] [Abstract][Full Text] [Related]